These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10363854)

  • 1. Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer.
    Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
    J Pediatr Hematol Oncol; 1999; 21(3):212-8. PubMed ID: 10363854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
    Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
    Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer.
    Teuffel O; Amir E; Alibhai SM; Beyene J; Sung L
    Pediatrics; 2011 Feb; 127(2):e279-86. PubMed ID: 21220399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
    Bash RO; Katz JA; Cash JV; Buchanan GR
    Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial.
    Hendricks AM; Loggers ET; Talcott JA
    J Clin Oncol; 2011 Oct; 29(30):3984-9. PubMed ID: 21931037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy.
    Cosler LE; Sivasubramaniam V; Agboola O; Crawford J; Dale D; Lyman GH
    Value Health; 2005; 8(1):47-52. PubMed ID: 15841893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.
    Teuffel O; Amir E; Alibhai S; Beyene J; Sung L
    Br J Cancer; 2011 Apr; 104(9):1377-83. PubMed ID: 21468048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and costs of treating neutropenic fever in an outpatient setting.
    Del Prete SA; Ryan SP; Jacobson JS; Erichson RB; Weinstein PL; Grann VR
    Conn Med; 1999 Dec; 63(12):713-7. PubMed ID: 10659471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial.
    Malik IA; Khan WA; Karim M; Aziz Z; Khan MA
    Am J Med; 1995 Mar; 98(3):224-31. PubMed ID: 7872337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients.
    Teuffel O; Cheng S; Ethier MC; Diorio C; Martino J; Mayo C; Wing R; Sung L; Alibhai SM
    Support Care Cancer; 2012 Nov; 20(11):2755-64. PubMed ID: 22350594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia.
    Elting LS; Lu C; Escalante CP; Giordano SH; Trent JC; Cooksley C; Avritscher EB; Shih YC; Ensor J; Bekele BN; Gralla RJ; Talcott JA; Rolston K
    J Clin Oncol; 2008 Feb; 26(4):606-11. PubMed ID: 18235119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disease and economic burden of neutropenic fever in adult patients in Australian cancer treatment centres 2008: analysis of the Victorian Admitted Episodes Dataset.
    Lingaratnam S; Thursky KA; Slavin MA; Kirsa SW; Bennett CA; Worth LJ
    Intern Med J; 2011 Jan; 41(1b):121-9. PubMed ID: 21272176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving concepts of management of febrile neutropenia in children with cancer.
    Orudjev E; Lange BJ
    Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient therapy for febrile neutropenia: clinical and economic implications.
    de Lalla F
    Pharmacoeconomics; 2003; 21(6):397-413. PubMed ID: 12678567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resource utilization and cost of episodes of febrile neutropenia in children with acute leukemias and lymphomas.
    Costa VC; Ferraz MB; Petrilli AS; Pereira CA; Rogerio JW
    Support Care Cancer; 2003 Jun; 11(6):356-61. PubMed ID: 12720070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.